Blackrock Science & Technology Term Trust

BlackRock Science and Technology Term Trust has entered into a standstill agreement with Saba Capital Management, limiting Saba's actions regarding the fund until 2027.

BlackRock Science & Technology Term Trust Vice President Stephen Thomas Minar reported multiple common stock acquisitions totaling 878 shares.

Tony Kim, Portfolio Manager for BlackRock Science & Technology Term Trust, reported recent purchases of common stock.

BlackRock Science & Technology Term Trust's Portfolio Manager, Tony Kim, reported the sale of common stock and the grant of new phantom shares.

A BlackRock Science & Technology Term Trust director reported the sale of all directly held common stock totaling 9,293.6469 shares under a pre-arranged plan.

Tony Kim, a Portfolio Manager at BlackRock Science & Technology Term Trust, acquired 27,000 shares of common stock on March 13, 2025.

Portfolio Manager Tony Kim reports acquisition and disposal of common stock and phantom shares in BlackRock Science & Technology Term Trust on January 31, 2025.

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock Closed-End Funds will hold a virtual joint annual meeting of shareholders on July 11, 2025, to vote on the election of board nominees.

BlackRock Science and Technology Term Trust (BSTZ) encourages shareholders to vote FOR the Board's nominees and AGAINST the proposal to terminate BlackRock as the investment manager at the upcoming annual meeting on July 16.

BlackRock is urging shareholders to vote against Saba Capital's proposals to install its own nominees and terminate BlackRock's investment management agreement for certain closed-end funds.

BlackRock urges shareholders to vote for its board nominees in BNY and BSTZ, highlighting preliminary results showing rejection of Saba's proposals.

BlackRock Science and Technology Term Trust (BSTZ) is urging shareholders to vote using the WHITE proxy card against Saba Capital's proposal to terminate BlackRock as the investment manager, highlighting BSTZ's strong performance and concerns about Saba's motives and expertise.

Saba Capital Management, L.P. and its affiliates have increased their beneficial ownership in BlackRock Science & Technology Term Trust to 7.94% through recent open market transactions.

Saba Capital Management, L.P. and its affiliates have increased their beneficial ownership in BlackRock Science & Technology Term Trust to 6.81%, holding 4,682,590 common shares.

Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 8 to their Schedule 13D, disclosing a 5.77% beneficial ownership in BlackRock Science & Technology Term Trust and detailing recent open market transactions, primarily sales.

Saba Capital Management, L.P. and its affiliates have reduced their beneficial ownership in BlackRock Science & Technology Term Trust to 7.02% through a series of open market sales.

BlackRock Science & Technology Term Trust has reached a standstill agreement with Saba Capital Management, L.P., a significant shareholder, resolving a prior shareholder proposal and outlining future engagement terms.